Opioid use after adult liver transplantation: Incidence, high-risk use, and adverse events in a large US cohort.

IF 5.6 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Hepatology Communications Pub Date : 2025-07-21 eCollection Date: 2025-08-01 DOI:10.1097/HC9.0000000000000765
Sarah R Lieber, Olgert Bardhi, Yue Jiang, Alex R Jones, Prajwal Gowda, Shannan R Tujios, William Tirone, Madhukar S Patel, Parsia Vagefi, Steven Hanish, Van Ngo, Mary Olumesi, Jessica F Whitt, Raelene Trudeau, Arjmand Mufti, Ben Lippe, Donna M Evon, Amit G Singal, Lisa B VanWagner
{"title":"Opioid use after adult liver transplantation: Incidence, high-risk use, and adverse events in a large US cohort.","authors":"Sarah R Lieber, Olgert Bardhi, Yue Jiang, Alex R Jones, Prajwal Gowda, Shannan R Tujios, William Tirone, Madhukar S Patel, Parsia Vagefi, Steven Hanish, Van Ngo, Mary Olumesi, Jessica F Whitt, Raelene Trudeau, Arjmand Mufti, Ben Lippe, Donna M Evon, Amit G Singal, Lisa B VanWagner","doi":"10.1097/HC9.0000000000000765","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Opioid use contributes to significant morbidity, posing specific risks to liver transplant recipients (LTRs). This study aimed to characterize outpatient opioid use before and after liver transplantation (LT) and identify risk factors for high-risk, incident, and chronic use and related complications.</p><p><strong>Methods: </strong>Adult LTRs were identified from 2006 to 2021 in IQVIA PharMetrics Plus for Academics, a claims database representative of the commercially insured US population. Opioid use was evaluated 30-365 days after LT; high-risk use was defined as >50 morphine milligram equivalents (MMEs) per day or concurrent opioid-benzodiazepine use. Factors associated with use, including high-risk use, were identified using multivariable logistic regression analysis. Landmark analyses assessed the association between outpatient opioid use 30-120 days post-LT and incident adverse events (eg, psychiatric, substance use, chronic pain, fractures/falls, digestive).</p><p><strong>Results: </strong>Among 1338 LTRs, 899 (67.2%) received outpatient opioid prescriptions >30 days post-LT, of whom 553 (41%) had incident use; 122 (13.6%) had high-risk opioid use. Factors significantly associated with high-risk use were female sex, pre-LT opioid use, and psychiatric disorder. Opioid use was significantly associated with increased adverse events 120-365 days post-LT; 59% of LTRs with opioid use within 1 year of LT developed complications compared to 39% of non-opioid users during this window (p<0.001). In adjusted landmark analyses, low/moderate opioid use within 30-120 days post-LT was associated with 1.87 times the hazard of complications compared to no opioid use at 120 days post-LT (95% CI: 1.14-3.07) and high-risk opioid use was associated with 2.87 (95% CI: 1.05-7.85) times the hazard.</p><p><strong>Conclusions: </strong>Post-LT opioid use is associated with increased risk of adverse events. Caution is needed in opioid prescribing beyond the perioperative period, particularly for those with preexisting psychiatric conditions.</p>","PeriodicalId":12978,"journal":{"name":"Hepatology Communications","volume":"9 8","pages":""},"PeriodicalIF":5.6000,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12282754/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatology Communications","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/HC9.0000000000000765","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Opioid use contributes to significant morbidity, posing specific risks to liver transplant recipients (LTRs). This study aimed to characterize outpatient opioid use before and after liver transplantation (LT) and identify risk factors for high-risk, incident, and chronic use and related complications.

Methods: Adult LTRs were identified from 2006 to 2021 in IQVIA PharMetrics Plus for Academics, a claims database representative of the commercially insured US population. Opioid use was evaluated 30-365 days after LT; high-risk use was defined as >50 morphine milligram equivalents (MMEs) per day or concurrent opioid-benzodiazepine use. Factors associated with use, including high-risk use, were identified using multivariable logistic regression analysis. Landmark analyses assessed the association between outpatient opioid use 30-120 days post-LT and incident adverse events (eg, psychiatric, substance use, chronic pain, fractures/falls, digestive).

Results: Among 1338 LTRs, 899 (67.2%) received outpatient opioid prescriptions >30 days post-LT, of whom 553 (41%) had incident use; 122 (13.6%) had high-risk opioid use. Factors significantly associated with high-risk use were female sex, pre-LT opioid use, and psychiatric disorder. Opioid use was significantly associated with increased adverse events 120-365 days post-LT; 59% of LTRs with opioid use within 1 year of LT developed complications compared to 39% of non-opioid users during this window (p<0.001). In adjusted landmark analyses, low/moderate opioid use within 30-120 days post-LT was associated with 1.87 times the hazard of complications compared to no opioid use at 120 days post-LT (95% CI: 1.14-3.07) and high-risk opioid use was associated with 2.87 (95% CI: 1.05-7.85) times the hazard.

Conclusions: Post-LT opioid use is associated with increased risk of adverse events. Caution is needed in opioid prescribing beyond the perioperative period, particularly for those with preexisting psychiatric conditions.

Abstract Image

Abstract Image

Abstract Image

成人肝移植后阿片类药物的使用:发生率、高风险使用和不良事件在一个大型美国队列中
背景:阿片类药物的使用导致了显著的发病率,对肝移植受者(LTRs)构成了特定的风险。本研究旨在描述肝移植(LT)前后门诊阿片类药物的使用情况,并确定高危、意外、慢性使用和相关并发症的危险因素。方法:从2006年到2021年,在IQVIA PharMetrics Plus for Academics(一个代表美国商业保险人口的索赔数据库)中确定成人ltr。LT后30-365天评估阿片类药物使用情况;高危使用被定义为每天使用50毫克吗啡当量(MMEs)或同时使用阿片类-苯二氮卓类药物。使用多变量logistic回归分析确定与使用相关的因素,包括高风险使用。里程碑式分析评估了术后30-120天门诊阿片类药物使用与不良事件(如精神、药物使用、慢性疼痛、骨折/跌倒、消化)之间的关系。结果:1338名ltr患者中,899名(67.2%)在lt后30天内获得门诊阿片类药物处方,其中553名(41%)有意外使用;122人(13.6%)有高危阿片类药物使用。与高危用药显著相关的因素是女性性别、lt前阿片类药物使用和精神障碍。阿片类药物使用与lt后120-365天不良事件增加显著相关;在肝移植后1年内使用阿片类药物的ltr患者中有59%出现并发症,而在此期间,非阿片类药物使用者的这一比例为39%(结论:肝移植后阿片类药物使用与不良事件风险增加有关)。围手术期后的阿片类药物处方需要谨慎,特别是对于那些先前存在精神疾病的人。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hepatology Communications
Hepatology Communications GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
8.00
自引率
2.00%
发文量
248
审稿时长
8 weeks
期刊介绍: Hepatology Communications is a peer-reviewed, online-only, open access journal for fast dissemination of high quality basic, translational, and clinical research in hepatology. Hepatology Communications maintains high standard and rigorous peer review. Because of its open access nature, authors retain the copyright to their works, all articles are immediately available and free to read and share, and it is fully compliant with funder and institutional mandates. The journal is committed to fast publication and author satisfaction. ​
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信